Quantcast

Latest Antivirals Stories

2015-03-05 08:30:49

EDISON, N.J., March 5, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.

2015-02-25 08:31:44

EDISON, N.J., Feb. 25, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.

2015-02-22 23:00:56

Indiana Fiber Network (IFN), the leading Indiana statewide Network Service Provider, announces hiring John Tackett as Deployment Supervisor. Indianapolis, Indiana

2015-02-20 16:26:06

EDISON, N.J., Feb. 20, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.

2015-02-12 00:21:30

- Submission based on Phase 3 GIFT-I study in patients with genotype 1b chronic hepatitis C virus infection NORTH CHICAGO, Ill., Feb.

2015-02-04 08:28:20

Receives Notice of Allowance for Composition of Matter Patent Extending Exclusivity Coverage to at least 2031 EDISON, N.J., Feb.

2015-02-02 08:27:39

EDISON, N.J., Feb. 2, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.

2015-01-16 04:21:11

- In Phase 3 clinical trials, VIEKIRAX + EXVIERA cured 95-100 percent of genotype 1 chronic hepatitis C patients, with less than 2 percent of patients experiencing virologic failure[1],[2]

2015-01-15 08:27:37

EDISON, N.J., Jan. 15, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related